DEXCOM INC's ticker is and the CUSIP is 252131AK3. A total of 63 filers reported holding DEXCOM INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,150,000 | – | 968,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SSI INVESTMENT MANAGEMENT LLC | 30,136,000 | $35,767,000 | 2.10% |
| PIER 88 INVESTMENT PARTNERS LLC | 7,865,000 | $9,338,000 | 1.98% |
| SHENKMAN CAPITAL MANAGEMENT INC | 23,555,000 | $27,465,000 | 1.87% |
| Lombard Odier Asset Management (Europe) Ltd | 242,782 | $28,776,000 | 1.27% |
| Cheyne Capital Management (UK) LLP | 1,410,000 | $1,674,000 | 1.09% |
| Fosun International Ltd | 12,712,000 | $15,064,000 | 0.86% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,086,000 | $28,580,000 | 0.48% |
| MACKAY SHIELDS LLC | 43,824,000 | $52,191,000 | 0.43% |
| Allianz Asset Management GmbH | 357,625,000 | $421,078,000 | 0.29% |
| BNP Paribas Asset Management Holding S.A. | 5,475,000 | $85,129,000 | 0.28% |